Australia - English - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - nebivolol hydrochloride, quantity: 1.36 mg (equivalent: nebivolol, qty 1.25 mg) - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; polysorbate 80; maize starch; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; lactose monohydrate - nebivolol is indicated: to treat essential hypertension; to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glenmark pharmaceuticals europe ltd - nebivolol hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - nebivolol hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - nebivolol hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - nebivolol hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - nebivolol hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

macleods pharma uk ltd - nebivolol hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - nebivolol hydrochloride - oral tablet - 10mg

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 2.725 mg (equivalent: nebivolol, qty 2.5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.